{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:04:11Z","timestamp":1793880251966,"version":"4.7.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.intimp.2012.11.007","type":"journal-article","created":{"date-parts":[[2012,11,21]],"date-time":"2012-11-21T21:34:58Z","timestamp":1353533698000},"page":"114-120","source":"Crossref","is-referenced-by-count":7,"title":["Effects of human umbilical cord-derived mesenchymal stem cells on anterior chamber-associated immune deviation"],"prefix":"10.1016","volume":"15","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaozhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong Chao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.intimp.2012.11.007_bb0005","first-page":"1940","article-title":"Ocular immune privilege and the Faustian dilemma. The Proctor lecture","volume":"37","author":"Streilein","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.intimp.2012.11.007_bb0010","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1442-9071.2005.01044.x","article-title":"Anterior chamber-associated immune deviation: a review of the anatomical evidence for the afferent arm of this unusual experimental model of ocular immune responses","volume":"33","author":"Camelo","year":"2005","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.intimp.2012.11.007_bb0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000099262","article-title":"Cross talk among cells promoting anterior chamber-associated immune deviation","volume":"92","author":"Stein-Streilein","year":"2007","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.intimp.2012.11.007_bb0020","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000099281","article-title":"Therapies based on principles of ocular immune privilege","volume":"92","author":"Zhang-Hoover","year":"2007","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.intimp.2012.11.007_bb0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000099251","article-title":"The induction of anterior chamber-associated immune deviation","volume":"92","author":"Niederkorn","year":"2007","journal-title":"Chem Immunol Allergy"},{"issue":"10","key":"10.1016\/j.intimp.2012.11.007_bb0030","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/eye.2008.382","article-title":"Ocular immune privilege","volume":"23","author":"Taylor","year":"2009","journal-title":"Eye (Lond)"},{"issue":"13","key":"10.1016\/j.intimp.2012.11.007_bb0035","first-page":"2700","article-title":"Anterior chamber-associated immune deviation promotes corneal allograft survival","volume":"37","author":"Niederkorn","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.intimp.2012.11.007_bb0040","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/02713689208999517","article-title":"Use of ACAID to suppress interphotoreceptor retinoid binding protein-induced experimental autoimmune uveitis","volume":"11","author":"Hara","year":"1992","journal-title":"Curr Eye Res"},{"issue":"1","key":"10.1016\/j.intimp.2012.11.007_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0897.2011.01069.x","article-title":"Immunomodulatory properties of mesenchymal stem cells: cytokines and factors","volume":"67","author":"Soleymaninejadian","year":"2012","journal-title":"Am J Reprod Immunol"},{"issue":"2","key":"10.1016\/j.intimp.2012.11.007_bb0050","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1167\/iovs.11-8211","article-title":"Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis","volume":"53","author":"Tasso","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.intimp.2012.11.007_bb0055","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","article-title":"Human mesenchymal stem cells modulate B-cell functions","volume":"107","author":"Corcione","year":"2006","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.intimp.2012.11.007_bb0060","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1182\/blood-2005-07-2775","article-title":"Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation","volume":"107","author":"Spaggiari","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2012.11.007_bb0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/01.tp.0000244572.24780.54","article-title":"Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle","volume":"83","author":"Ramasamy","year":"2007","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.intimp.2012.11.007_bb0070","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1159\/000329980","article-title":"Intrapulmonary delivery of human umbilical cord mesenchymal stem cells attenuates acute lung injury by expanding CD4+CD25+ Forkhead Boxp3 (FOXP3)+ regulatory T cells and balancing anti- and pro-inflammatory factors","volume":"27","author":"Sun","year":"2011","journal-title":"Cell Physiol Biochem"},{"issue":"10","key":"10.1016\/j.intimp.2012.11.007_bb0075","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1016\/j.transproceed.2009.08.072","article-title":"Bone marrow-derived mesenchymal stem cells inhibit acute rejection of rat liver allografts in association with regulatory T-cell expansion","volume":"41","author":"Wang","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.intimp.2012.11.007_bb0080","article-title":"Immunosuppressive properties of mesenchymal stem cells: advances and applications","author":"De Miguel","year":"2012","journal-title":"Curr Mol Med"},{"issue":"1","key":"10.1016\/j.intimp.2012.11.007_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2011.04327.x","article-title":"Immunomodulatory properties and therapeutic application of mesenchymal stem cells","volume":"164","author":"Shi","year":"2011","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.intimp.2012.11.007_bb0090","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s12015-009-9076-y","article-title":"Role of mesenchymal stem cells in immunological rejection of organ transplantation","volume":"5","author":"Zhang","year":"2009","journal-title":"Stem Cell Rev"},{"issue":"6","key":"10.1016\/j.intimp.2012.11.007_bb0095","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1167\/iovs.10-6334","article-title":"Mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity","volume":"52","author":"Zhang","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.intimp.2012.11.007_bb0100","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.exer.2012.06.008","article-title":"Immunomodulatory effects of mesenchymal stem cells in a rat corneal allograft rejection model","volume":"102","author":"Jia","year":"2012","journal-title":"Exp Eye Res"},{"issue":"8","key":"10.1016\/j.intimp.2012.11.007_bb0105","first-page":"1017","article-title":"Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials","volume":"91","author":"Lu","year":"2006","journal-title":"Haematologica"},{"issue":"3\u20134","key":"10.1016\/j.intimp.2012.11.007_bb0110","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000233255","article-title":"Therapeutic benefit of human umbilical cord derived mesenchymal stromal cells in intracerebral hemorrhage rat: implications of anti-inflammation and angiogenesis","volume":"24","author":"Liao","year":"2009","journal-title":"Cell Physiol Biochem"},{"issue":"3","key":"10.1016\/j.intimp.2012.11.007_bb0115","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/TP.0b013e318195742e","article-title":"Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke","volume":"87","author":"Liao","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.intimp.2012.11.007_bb0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2172-9-53","article-title":"Upregulation of CD94 on CD8+T cells in anterior chamber-associated immune deviation","volume":"9","author":"He","year":"2008","journal-title":"BMC Immunol"},{"issue":"4","key":"10.1016\/j.intimp.2012.11.007_bb0125","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1084\/jem.152.4.1121","article-title":"Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens","volume":"152","author":"Streilein","year":"1980","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2012.11.007_bb0130","first-page":"968","article-title":"Increased expression of Foxp3 in splenic CD8+ T cells from mice with anterior chamber-associated immune deviation","volume":"13","author":"Jiang","year":"2007","journal-title":"Mol Vis"},{"issue":"7","key":"10.1016\/j.intimp.2012.11.007_bb0135","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.4049\/jimmunol.153.7.2962","article-title":"Imposing deviant immunity on the presensitized state","volume":"153","author":"Kosiewicz","year":"1994","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2012.11.007_bb0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1365-2567.2003.01676.x","article-title":"CD25+, interleukin-10-producing CD4+ T cells are required for suppressor cell production and immune privilege in the anterior chamber of the eye","volume":"110","author":"Skelsey","year":"2003","journal-title":"Immunology"},{"issue":"12","key":"10.1016\/j.intimp.2012.11.007_bb0145","doi-asserted-by":"crossref","first-page":"8331","DOI":"10.4049\/jimmunol.177.12.8331","article-title":"Gammadelta T cells promote anterior chamber-associated immune deviation and immune privilege through their production of IL-10","volume":"177","author":"Ashour","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2012.11.007_bb0150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000058827","article-title":"Gamma-delta T cells: immunoregulatory functions and immunoprotection","volume":"79","author":"Cai","year":"2001","journal-title":"Chem Immunol"},{"key":"10.1016\/j.intimp.2012.11.007_bb0155","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev.immunol.24.021605.090737","article-title":"Transforming growth factor-beta regulation of immune responses","volume":"24","author":"Li","year":"2006","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2012.11.007_bb0160","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00417-008-0947-8","article-title":"Splenic CD8+ T cells secrete TGF-beta1 to exert suppression in mice with anterior chamber-associated immune deviation","volume":"247","author":"Jiang","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.intimp.2012.11.007_bb0165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1365-2567.1996.d01-714.x","article-title":"Role of Th1 and Th2 cells in anterior chamber-associated immune deviation","volume":"89","author":"Li","year":"1996","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.intimp.2012.11.007_bb0170","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.4049\/jimmunol.144.5.1767","article-title":"Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression","volume":"144","author":"Ruegemer","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2012.11.007_bb0175","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol Rev"},{"issue":"4","key":"10.1016\/j.intimp.2012.11.007_bb0180","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"issue":"12","key":"10.1016\/j.intimp.2012.11.007_bb0185","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.intimp.2010.06.019","article-title":"The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy","volume":"10","author":"Hoogduijn","year":"2010","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.intimp.2012.11.007_bb0190","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.molmed.2011.10.004","article-title":"The immunomodulatory capacity of mesenchymal stem cells","volume":"18","author":"Gebler","year":"2012","journal-title":"Trends Mol Med"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576912003281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576912003281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T22:22:15Z","timestamp":1687818135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576912003281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1567576912003281"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2012.11.007","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}